The April update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of this month’s update include:
New AHFS PMI Monographs
- Buprenorphine Buccal (Belbuca®), indicated for severe chronic pain
- Emtricitabine/Rilpivirine/Tenofovir (Complera®), indicated for HIV infection
- Lesinurad (Zurampic®), indicated for hyperuricemia in people with gout
- Posaconazole Injection (Noxafil®), indicated for prevention of fungal infections in people with weakened ability to fight infections
FDA MedWatch Alerts
- New safety warnings for opioids
- Risk of heart failure for alogliptin and saxagliptin
- New safety warning for metformin in patients with reduced kidney function
